Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Inventory: 2019-2025

Historic Inventory for Harmony Biosciences Holdings (HRMY) over the last 5 years, with Sep 2025 value amounting to $7.0 million.

  • Harmony Biosciences Holdings' Inventory rose 1.89% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year increase of 1.89%. This contributed to the annual value of $7.2 million for FY2024, which is 34.22% up from last year.
  • Harmony Biosciences Holdings' Inventory amounted to $7.0 million in Q3 2025, which was up 12.47% from $6.3 million recorded in Q2 2025.
  • Harmony Biosciences Holdings' Inventory's 5-year high stood at $7.2 million during Q4 2024, with a 5-year trough of $4.5 million in Q3 2022.
  • For the 3-year period, Harmony Biosciences Holdings' Inventory averaged around $6.0 million, with its median value being $5.9 million (2024).
  • As far as peak fluctuations go, Harmony Biosciences Holdings' Inventory skyrocketed by 121.68% in 2021, and later dropped by 13.37% in 2022.
  • Harmony Biosciences Holdings' Inventory (Quarterly) stood at $4.9 million in 2021, then grew by 0.72% to $4.9 million in 2022, then increased by 9.09% to $5.4 million in 2023, then skyrocketed by 34.22% to $7.2 million in 2024, then rose by 1.89% to $7.0 million in 2025.
  • Its last three reported values are $7.0 million in Q3 2025, $6.3 million for Q2 2025, and $6.5 million during Q1 2025.